$AGIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AGIOS PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AGIOS PHARMACEUTICALS, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 35.06 | 3,532 | 123,832 | 0 | 3.5 K to 0 (-100.00 %) |
| Feb 20 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.47 | 3,532 | 1,651 | 3,532 | 0 to 3.5 K |
| Feb 20 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 2,354 | 712 | 328,686 | |
| Feb 20 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 35.06 | 2,354 | 82,531 | 109,090 | 111.4 K to 109.1 K (-2.11 %) |
| Feb 20 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 2,354 | 712 | 111,444 | 109.1 K to 111.4 K (+2.16 %) |
| Feb 11 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.47 | 6,000 | 2,805 | 99,271 | |
| Feb 11 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 30.44 | 6,000 | 182,640 | 0 | 6 K to 0 (-100.00 %) |
| Feb 11 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.47 | 6,000 | 2,805 | 6,000 | 0 to 6 K |
| Feb 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 8,000 | 2,420 | 331,040 | |
| Feb 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 25.97 | 8,000 | 207,728 | 109,090 | 117.1 K to 109.1 K (-6.83 %) |
| Feb 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 8,000 | 2,420 | 117,090 | 109.1 K to 117.1 K (+7.33 %) |
| Feb 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 6,000 | 2,805 | 246,090 | |
| Feb 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 25.97 | 6,000 | 155,796 | 0 | 6 K to 0 (-100.00 %) |
| Feb 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 6,000 | 2,805 | 6,000 | 0 to 6 K |
| Jan 28 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.47 | 7,000 | 3,273 | 105,271 | |
| Jan 28 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 26.29 | 7,000 | 184,051 | 0 | 7 K to 0 (-100.00 %) |
| Jan 28 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.47 | 7,000 | 3,273 | 7,000 | 0 to 7 K |
| Jan 23 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 6,000 | 2,805 | 252,090 | |
| Jan 23 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 34.71 | 6,000 | 208,265 | 0 | 6 K to 0 (-100.00 %) |
| Jan 23 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 6,000 | 2,805 | 6,000 | 0 to 6 K |
| Jan 23 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 12,000 | 3,630 | 339,040 | |
| Jan 23 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 34.71 | 12,000 | 416,530 | 109,090 | 121.1 K to 109.1 K (-9.91 %) |
| Jan 23 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 12,000 | 3,630 | 121,090 | 109.1 K to 121.1 K (+11.00 %) |
| Jan 22 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.47 | 10,000 | 4,675 | 112,271 | |
| Jan 22 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | A | 9.05 | 3,636 | 32,906 | 122,271 | |
| Jan 22 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 34.71 | 10,000 | 347,108 | 0 | 10 K to 0 (-100.00 %) |
| Jan 22 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.47 | 10,000 | 4,675 | 10,000 | 0 to 10 K |
| Dec 06 2013 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | A | 18.01 | 1,500 | 27,015 | 23,500 | |
| Dec 06 2013 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 18.01 | 10,000 | 180,100 | 10,000 | |
| Dec 06 2013 | AGIO | AGIOS PHARMACEUTIC ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 18.01 | 10,750 | 193,608 | 15,113 | |
| Sep 26 2013 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | A | 25.78 | 22,000 | 567,160 | 22,000 | |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | STARR KEVIN P | Director | Option Exercise | C | 0.00 | 802,141 | 0 | 0 | |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | STARR KEVIN P | Director | Option Exercise | C | 0.00 | 13,000,000 | 0 | 0 | |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | STARR KEVIN P | Director | Buy | C | 0.00 | 5,018,960 | 0 | 5,564,414 | 545.5 K to 5.6 M (+920.14 %) |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | THIRD ROCK VENTURES LP | 10% Owner | Option Exercise | C | 0.00 | 802,141 | 0 | 0 | |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | THIRD ROCK VENTURES LP | 10% Owner | Option Exercise | C | 0.00 | 13,000,000 | 0 | 0 | |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | THIRD ROCK VENTURES LP | 10% Owner | Buy | C | 0.00 | 5,018,960 | 0 | 5,564,414 | 545.5 K to 5.6 M (+920.14 %) |
| Sep 05 2013 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | A | 23.10 | 55,000 | 1,270,500 | 118,635 | |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | Flagship Ventures Fund 2007, L ... | 10% Owner | Option Exercise | C | 0.00 | 617,031 | 0 | 0 | |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | Flagship Ventures Fund 2007, L ... | 10% Owner | Option Exercise | C | 0.00 | 10,000,000 | 0 | 0 | |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | Flagship Ventures Fund 2007, L ... | 10% Owner | Buy | C | 0.00 | 3,860,738 | 0 | 3,860,738 | 0 to 3.9 M |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 617,031 | 0 | 0 | |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 10,000,000 | 0 | 0 | |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 3,860,738 | 0 | 3,860,738 | 0 to 3.9 M |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 617,031 | 0 | 0 | |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 10,000,000 | 0 | 0 | |
| Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 3,860,738 | 0 | 3,860,738 | 0 to 3.9 M |
| Jul 30 2013 | AGIO | AGIOS PHARMACEUTIC ... | Celgene European Investment Co ... | 10% Owner | Option Exercise | C | 0.00 | 5,839,496 | 0 | 0 | |
| Jul 30 2013 | AGIO | AGIOS PHARMACEUTIC ... | Celgene European Investment Co ... | 10% Owner | Option Exercise | C | 0.00 | 5,190,551 | 0 | 0 | |
| Jul 30 2013 | AGIO | AGIOS PHARMACEUTIC ... | Celgene European Investment Co ... | 10% Owner | Buy | P | 18.00 | 708,333 | 12,749,994 | 708,333 | 0 to 708.3 K |
| Jul 30 2013 | AGIO | AGIOS PHARMACEUTIC ... | Celgene European Investment Co ... | 10% Owner | Buy | C | 0.00 | 2,123,453 | 0 | 4,010,926 | 1.9 M to 4 M (+112.50 %) |
| Jul 30 2013 | AGIO | AGIOS PHARMACEUTIC ... | Celgene European Investment Co ... | 10% Owner | Buy | C | 0.00 | 1,887,473 | 0 | 1,887,473 | 0 to 1.9 M |